Kim M. Smits

3.2k total citations · 1 hit paper
37 papers, 1.7k citations indexed

About

Kim M. Smits is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kim M. Smits has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Kim M. Smits's work include Epigenetics and DNA Methylation (17 papers), Renal cell carcinoma treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kim M. Smits is often cited by papers focused on Epigenetics and DNA Methylation (17 papers), Renal cell carcinoma treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kim M. Smits collaborates with scholars based in Netherlands, United States and Belgium. Kim M. Smits's co-authors include Manon van Engeland, James G. Herman, Veerle Melotte, Alexander Koch, Sophie C. Joosten, Wim Van Criekinge, Leander Van Neste, Muriel X.G. Draht, Martin H. Prins and Luc Smits and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Kim M. Smits

36 papers receiving 1.7k citations

Hit Papers

Analysis of DNA methylation in cancer: location revisited 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim M. Smits Netherlands 22 1.1k 497 430 324 177 37 1.7k
Astrid Weyerbrock Germany 28 541 0.5× 394 0.8× 364 0.8× 285 0.9× 117 0.7× 97 2.2k
Daniel T. Merrick United States 23 1.0k 1.0× 733 1.5× 485 1.1× 703 2.2× 106 0.6× 51 2.0k
Leonie Jestaedt Germany 13 725 0.7× 233 0.5× 260 0.6× 270 0.8× 175 1.0× 16 2.1k
Avelina Tortosa Spain 27 1.3k 1.2× 263 0.5× 427 1.0× 475 1.5× 111 0.6× 50 2.4k
Isabel Tritschler Switzerland 12 1.1k 1.0× 179 0.4× 445 1.0× 518 1.6× 80 0.5× 15 2.6k
Shuhei Suzuki Japan 26 1.1k 1.0× 168 0.3× 328 0.8× 509 1.6× 132 0.7× 116 2.0k
Wenli Dong United States 27 852 0.8× 319 0.6× 518 1.2× 616 1.9× 341 1.9× 74 2.2k
Ying Xiong China 22 529 0.5× 331 0.7× 281 0.7× 409 1.3× 134 0.8× 92 1.5k
Israel Fernández‐Cadenas Spain 30 1.1k 1.1× 349 0.7× 505 1.2× 100 0.3× 47 0.3× 108 2.9k
Nicholas B. Jennings United States 27 1.3k 1.2× 202 0.4× 439 1.0× 718 2.2× 173 1.0× 45 2.5k

Countries citing papers authored by Kim M. Smits

Since Specialization
Citations

This map shows the geographic impact of Kim M. Smits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim M. Smits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim M. Smits more than expected).

Fields of papers citing papers by Kim M. Smits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim M. Smits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim M. Smits. The network helps show where Kim M. Smits may publish in the future.

Co-authorship network of co-authors of Kim M. Smits

This figure shows the co-authorship network connecting the top 25 collaborators of Kim M. Smits. A scholar is included among the top collaborators of Kim M. Smits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim M. Smits. Kim M. Smits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moonen, Laura, Jules L. Derks, Michael A. den Bakker, et al.. (2024). OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid. Modern Pathology. 38(3). 100677–100677. 3 indexed citations
2.
Samarska, Iryna, Andrés Matoso, Marcella Baldewijns, et al.. (2023). Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification. Oncology Letters. 25(5). 5 indexed citations
3.
Wouters, Kristien, Johan Vandersmissen, Wim Van Criekinge, et al.. (2022). Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. Clinical Epigenetics. 14(1). 56–56. 9 indexed citations
4.
Koch, Alexander, Muriel X.G. Draht, Kristien Wouters, et al.. (2021). Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Clinical Epigenetics. 13(1). 80–80. 25 indexed citations
5.
Jenniskens, Josien C.A., Kelly Offermans, Iryna Samarska, et al.. (2021). Validity and Reproducibility of Immunohistochemical Scoring by Trained Non-Pathologists on Tissue Microarrays. Cancer Epidemiology Biomarkers & Prevention. 30(10). 1867–1874. 7 indexed citations
6.
Vaes, Nathalie, Maureen J.B. Aarts, Joep G.H. van Roermund, et al.. (2019). Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review. European Urology Oncology. 4(2). 215–226. 18 indexed citations
7.
Draht, Muriel X.G., Alexander Koch, Heike I. Grabsch, et al.. (2018). Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical Epigenetics. 10(1). 35–35. 34 indexed citations
8.
Joosten, Sophie C., Kim M. Smits, Maureen J.B. Aarts, et al.. (2018). Epigenetics in renal cell cancer: mechanisms and clinical applications. Nature Reviews Urology. 15(7). 430–451. 114 indexed citations
9.
Vlodrop, Iris J.H. van, Sophie C. Joosten, Tim De Meyer, et al.. (2016). A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. Clinical Cancer Research. 23(8). 2006–2018. 44 indexed citations
10.
Melotte, Veerle, Joo Mi Yi, Marjolein H.F.M. Lentjes, et al.. (2014). Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood. Cancer Prevention Research. 8(2). 157–164. 31 indexed citations
11.
Cleven, Arjen H.G., Sarah Derks, Muriel X.G. Draht, et al.. (2014). CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 20(12). 3261–3271. 30 indexed citations
12.
Nalbantov, Georgi, Bas Kietselaer, Katrien Vandecasteele, et al.. (2013). Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiotherapy and Oncology. 109(1). 100–106. 47 indexed citations
13.
Derks, Sarah, Arjen H.G. Cleven, Veerle Melotte, et al.. (2013). Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine. Cancer and Metastasis Reviews. 33(1). 161–71. 35 indexed citations
14.
Smits, Kim M., Pauline de Graeff, G. Bea A. Wisman, et al.. (2010). Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. Modern Pathology. 24(3). 463–470. 28 indexed citations
15.
Smits, Kim M., Leo J. Schouten, Bas A.J. Verhage, et al.. (2010). Body Mass Index and von Hippel-Lindau Gene Mutations in Clear-cell Renal Cancer: Results of the Netherlands Cohort Study on Diet and Cancer. Annals of Epidemiology. 20(5). 401–404. 8 indexed citations
16.
Vlodrop, Iris J.H. van, Marcella Baldewijns, Kim M. Smits, et al.. (2009). Prognostic Significance of Gremlin1 (GREM1) Promoter CpG Island Hypermethylation in Clear Cell Renal Cell Carcinoma. American Journal Of Pathology. 176(2). 575–584. 67 indexed citations
17.
Smits, Kim M., Luc Smits, Frenk Peeters, et al.. (2008). The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Psychiatric Genetics. 18(4). 184–190. 44 indexed citations
18.
Brandt, Piet A. van den, Kim M. Smits, R. Alexandra Goldbohm, & Matty P. Weijenberg. (2007). Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study. British Journal of Cancer. 96(3). 510–513. 33 indexed citations
19.
Smits, Kim M., Luc Smits, Frenk Peeters, et al.. (2007). Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. International Clinical Psychopharmacology. 22(3). 137–143. 48 indexed citations
20.
Smits, Kim M., Luc Smits, Jan Schouten, et al.. (2004). Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Molecular Psychiatry. 9(5). 433–441. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026